3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Hematologic Neoplasms
3
Primary Myelofibrosis
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Myeloproliferative Disorders
2
Myelodysplastic Syndromes
2
Lymphoma, Non-Hodgkin
2
Leukemia, Myeloid, Chronic-Phase
2
Leukemia, Myeloid, Acute
2
Leukemia, Myeloid, Accelerated Phase
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Hodgkin Disease
2
Multiple Myeloma
1
Cytomegalovirus Infections
1
Interventions
Cyclophosphamide
9
mogamulizumab
6
Biopsy
6
fludarabine
5
fludarabine phosphate
4
Specimen Handling
4
Immunoglobulin G
4
Disulfides
4
Brentuximab Vedotin
4
ruxolitinib
3
romidepsin
3
pembrolizumab
3
Peripheral Blood Stem Cell Transplantation
3
Mycophenolic Acid
3
Magnetic Resonance Spectroscopy
3
Lenalidomide
3
Etoposide
3
Busulfan
3
hypericin
2
Whole-Body Irradiation
2
Vincristine
2
Tacrolimus
2
Prednisone
2
Nivolumab
2
Melphalan
2
Depsipeptides
2
Bexarotene
2
tofacitinib
1
thymoglobulin
1
tazemetostat
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, T-Cell, Cutaneous
×
letermovir
×
1 year
×
Clear all
No trials found.